| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 636087 | Null | 0.0267520285931239 | -0.30764099 |
| NSC 643826 | 8-Aza-3,5-dioxa-4-phosphahexacosan-1-aminium, 4-hydroxy- 7-(methoxymethyl)-8,N,N,N-tetramethyl-, inner salt,4-oxide | 0.0267520285931239 | -0.059340964 |
| NSC 651654 | Null | 0.0267520285931239 | -0.22736971 |
| NSC 664529 | Null | 0.0267520285931239 | -0.14513157 |
| NSC 671367 | Null | 0.0267520285931239 | -0.37288635 |
| NSC 67774 | Null | 0.0267520285931239 | 0.39112594 |
| NSC 680935 | 2H-Furo[3',2':3,4]benzopyrano[6,7-b]pyridine- 2,6,11-trione, 2,3-dihydro-5,5,8-trimethyl- | 0.0267520285931239 | -0.26042361 |
| NSC 681642 | Camptothecin Derivative | 0.0267520285931239 | -0.043892031 |
| NSC 682096 | Quinolinium, 4-amino-2-methyl-1-[10-[(2-methyl- 4-quinolinyl)amino]decyl]-, chloride, monohydrochloride | 0.0267520285931239 | -0.22531294 |
| NSC 682689 | 2,4,16-Tribromoestra-1,3,5(10)-trien-3-ol-17-one | 0.0267520285931239 | -0.15087889 |